Catherine Dunyach-Remy
Overview
Explore the profile of Catherine Dunyach-Remy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
980
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Durand B, Daher R, Grenga L, Morsli M, Armengaud J, Lavigne J, et al.
BMC Microbiol
. 2024 Oct;
24(1):406.
PMID: 39394082
Background: Staphylococcus aureus is the predominant pathogen isolated in diabetic foot infections. Recently, the skin commensal bacterium, Helcococcus kunzii, was found to modulate the virulence of this pathogen in an...
2.
Majdi C, Duvauchelle V, Seghir M, Benimelis D, Dunyach-Remy C, Dessolin J, et al.
Int J Antimicrob Agents
. 2024 Aug;
64(4):107298.
PMID: 39122054
No abstract available.
3.
Majdi C, Seghir M, Wegrich Y, Behilil D, Benimelis D, Dunyach-Remy C, et al.
Bioorg Chem
. 2024 Jul;
150:107627.
PMID: 38996547
1,4-naphthoquinones hydroxyderivatives belong to an important class of natural products and have been known as a favored scaffold in medicinal chemistry due to their multiple biological properties. Juglone is one...
4.
Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project
Bardol T, Dujon A, Taly V, Dunyach-Remy C, Lavigne J, Costa-Silva B, et al.
BMC Cancer
. 2024 Jun;
24(1):709.
PMID: 38853244
Background: Pancreatic cancer, predominantly characterized by ductal adenocarcinoma (PDAC) accounts for 90% of cases and is the fourth leading cause of cancer-related deaths globally. Its incidence is notably increasing. This...
5.
Emergence of multidrug-resistant in neonatal intensive care unit in Southern France, a genomic study
Magnan C, Morsli M, Salipante F, Thiry B, Attar J, Di Maio M, et al.
Emerg Microbes Infect
. 2024 May;
13(1):2353291.
PMID: 38738561
An emergence of multidrug-resistant (MDR) has been observed in the neonatal intensive care unit (NICU) of Nîmes University Hospital in southern France. A case-control analysis was conducted on 96 neonates,...
6.
Morsli M, Salipante F, Magnan C, Dunyach-Remy C, Sotto A, Lavigne J
Ann Clin Microbiol Antimicrob
. 2024 May;
23(1):39.
PMID: 38702796
Background: Non-surgical chronic wounds, including diabetes-related foot diseases (DRFD), pressure injuries (PIs) and venous leg ulcers (VLU), are common hard-to-heal wounds. Wound evolution partly depends on microbial colonisation or infection,...
7.
Laffont-Lozes P, Larcher R, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne J, et al.
Antimicrob Resist Infect Control
. 2024 Mar;
13(1):33.
PMID: 38515203
No abstract available.
8.
Majdi C, Dessolin J, Benimelis D, Dunyach-Remy C, Pantel A, Meffre P, et al.
Bioorg Med Chem
. 2024 Jan;
100:117604.
PMID: 38290306
Colistin is considered as the last-resort antibiotics to treat multi-drug resistant Gram-negative bacterial infections in humans. However, the clinical use of colistin was limited because of the apparition of chromosomal...
9.
Morsli M, Salipante F, Gelis A, Magnan C, Guigon G, Lavigne J, et al.
Int Wound J
. 2024 Jan;
21(1):e14626.
PMID: 38272816
Current microbiome investigations of patients with pressure ulcers (PU) are mainly based on wound swabs and/or biopsy sequencing, leaving the colonization scenario unclear. Urinary microbiota has been never studied. As...
10.
Magnan C, Lancry T, Salipante F, Trusson R, Dunyach-Remy C, Roger C, et al.
Front Cell Infect Microbiol
. 2024 Jan;
13:1330900.
PMID: 38179421
Introduction: Sepsis is a life-threatening organ dysfunction with high mortality rate. The gut origin hypothesis of multiple organ dysfunction syndrome relates to loss of gut barrier function and the ensuing...